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Background: Mitochondrial proteomic alterations of nasopharyngeal carcinoma metastasis remain unknown. Our
purpose is to screen mitochondrial proteins for the elucidation of the molecular mechanisms of nasopharyngeal
carcinoma metastasis and the discovery of metastasis-related biomarkers.
Methods: Mitochondria were isolated from nasopharyngeal carcinoma metastatic (5-8F) and nonmetastatic (6-10B)
cell lines, respectively. After characterization of isolated mitochondria, mitochondrial differentially expressed proteins
(DEPs) were quantified by two-dimensional difference in-gel electrophoresis (2D-DIGE), and identified by peptide
mass fingerprint (PMF) and tandem mass spectrometry (MS/MS). A functional enrichment analysis and a
protein-protein interaction sub-network analysis for DEPs were carried out with bioinformatics. Furthermore, siRNAs
transient transfections were used to suppress expressions of some up-regulated DEPs in metastatic cells (5-8F),
followed by Transwell Migration assay.
Results: Sixteen mitochondrial DEPs including PRDX3 and SOD2 were identified. Those 5-8F cells with suppression
of PRDX3 showed an increased mobility potential. The functional enrichment analyses of DEPs discovered five
significant biological processes including cellular response to reactive oxygen species, hydrogen peroxide metabolic
process, regulation of mitochondrial membrane potential, cell redox homeostasis and oxidation reduction, and five
significant molecular functions including oxidoreductase activity, caspase inhibitor activity, peroxiredoxin activity,
porin activity and antioxidant activity. A protein-protein interaction sub-network of DEPs was generated with
literature data. Ten mitochondrial DEPs including PRDX3, PRDX6, SOD2, ECH1, SERPINB5, COX5A, PDIA5, EIF5A,
IDH3B, and PSMC4 were rationalized in the tumor-stroma co-evolution model that mitochondrial oxidative stress
directly contributes to tumor metastasis.
Conclusions: Sixteen mitochondrial DEPs were identified with mass spectrometry and ten of them were
rationalized in the tumor-stroma co-evolution model. Those 5-8F cells with suppression of PRDX3 showed an
increased mobility potential. These data suggest that those mitochondrial DEPs are potential biomarkers for NPC
metastasis, and their dysregulation would play important roles in mitochondria oxidative stress-mediated NPC
metastatic process.
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Nasopharyngeal carcinoma (NPC) cell lines 5-8F and 6-
10B are derived from the same human cell line SUNE1
that is derived from a female poorly differentiated naso-
pharyngeal squamous epithelial cell carcinoma. Those
two cell sublines 5-8F and 6-10B with the same genetic
background have tumorigenic ability that was confirmed
by the colony formation in soft agar and in vivo mouse
model, but are quite different in metastatic potential [1-
3]. 5-8F cells are metastatic and 6-10B cells are nonme-
tastatic, which was confirmed by in vivo mouse model
[2]. This different biological character shows that these
two cell sublines are the useful experiment materials to
study the molecular events of NPC metastasis. Based on
those two subcelines, some research groups analyzed the
differentially expressed genes (DEGs) and differentially
expressed proteins (DEPs) using the whole-cell samples
of those two cell lines. A total of 78 DEGs were identi-
fied with subtractive suppression hybridization [4] and
microarray [5]. Of them, 11 DEGs including PTHLH
formed a metastasis-related gene network [5]. A total of
28 DEPs were identified with two-dimensional gel elec-
trophoresis (2DGE) coupled with matrix-assisted laser
desorption ionization time-of-flight mass spectrometry
(MALDI-TOF MS) [6,7]. Those DEPs were related to
apoptosis, cell cycle, cell signal transduction, cell sur-
vival, transcription regulation, cell mobility, protein syn-
thesis, and DNA damage repair [6,7]. However, those
DEGs and DEPs were not fully rationalized in the bio-
logical process of NPC metastasis, and there is no any
overlap between those 78 DEGs and 28 DEPs [4-7]. It
would be derived from the following limitation factors:
(i) the range of the protein abundance of the whole-cell
sample is too wide, not all proteins were extracted; (ii)
2DGE only can array very small partial components of a
whole-cell proteome, and (iii) the process of translation
of DEG to DEP is regulated by multiple factors, which
results in the low consistence between the DEG and
DEP profiles. The subcellular proteomics such as just fo-
cusing on one compartment of a cell would more effect-
ively discover function-related proteins because the
subcellular proteome is much simpler than the whole-
cell proteome, it can maximally identify the protein
components in a subcellular proteome.
Many evidences have demonstrated that mitochondria
is the central to oxidative stress, and tumor cell self has
anti-oxidant ability for its survival and metastasis [8-15].
Mitochondria are not just innocent bystander in cancer,
but are related to tumorigenesis, apoptosis, cancer ther-
apy and metastasis. The contribution of mitochondria to
cancer involves three critical processes including alterations
in glucose metabolism, production of reactive oxygen spe-
cies (ROS), and compromise of intrinsic apoptotic function
[8,9]. According to the tumor-stroma co-evolution modelopinion, cancer cells secrete hydrogen peroxide, induce
oxidative stress in adjacent stromal cells, and result in an
excess production of ROS in mitochondria. Excess stromal
ROS induces cytoskeleton rearrangements, autophagy, and
mitophagy in the tumor microenvironment to help cancer
cells escape excess ROS in the primary tumor site, also
induces the stromal over-production of recycled nutrients
such as ketones and L-lactate that are fuel for tumor
growth and metastasis [10-14]. This model provides fresh
insight of how mitochondria involved in tumor metastasis.
Therefore, a tight relationship exists between mitochondria
and tumor metastasis. However, the causes, consequences,
and other series of related questions regarding molecular
mechanism of mictochondria in tumor metastasis still re-
main unclear. Thus, this current work focused on the
mitochondrial proteome difference between metastatic 5-
8F and 6-10B cells, and provided clues to clarification of
the functional role of mitochondria in the process of NPC
metastasis.
In order to screen mitochondrial proteins for the elu-
cidation of the mechanism of NPC metastasis and the
discovery of metastasis-related biomarkers, two-
dimensional difference in-gel electrophoresis (2D-DIGE)
was used to determine mitochondrial DEPs between
metastatic 5-8F and nonmetastastic 6-10B cells, followed
by protein characterization with peptide mass fingerprint
(PMF) and tandem mass spectrometry (MS/MS). siRNA
transient transfection was used to suppress the expres-
sions of up-regulated DEPs in metastatic 5-8F cells, fol-
lowed by the observation of changes in cell mobility
potential by Transwell Migration assay. Cytoscape
BiNGO plugin was used for gene ontology (GO) analyses
of DEPs to identify the enriched biological processes and
molecular functions. A protein-protein interaction sub-
network of DEPs was generated with literature data min-
ing from HPRD and NCBI databases. Ten DEPs were
rationalized in a tumor-stroma co-evolution model, and
associated with tumor metastasis.
Results
Characterization of isolated mitochondria
The purity of isolated mitochondria was assessed by West-
ern blotting and electron microscopic observations.
Figure 1A showed Western blotting images of extracted
proteins from isolated mitochondrial samples against
known marker proteins from cytoplasm (LDH), mitochon-
dria (COX IV), nucleus (PCNA), endoplasmic reticulum
(GRP 78), peroxisome (catalase), and lysosome (Cathepsin
D). Mitochondrial protein COX IV was specifically
detected in isolated mitochondrial sample and this sample
lacked any detectable contamination of abundant cytosolic
(LDH), nuclear (PCNA), and endoplasmic reticulum pro-
teins (GRP78), except for detectable contamination of
catalase from peroxisome and cathepsin D from lysosome.
Figure 1 Characterization of isolated mitochondria from cells.
A. Western blotting images of 6 marker proteins in the whole-cell
protein samples (left column) and the isolated mitochondrial protein
samples (right column). A total of 60 μg proteins was loaded and
isolated by 12% SDS-PAGE, and transferred to PVDF membrane and
incubated with primary antibodies (dilution 1:500) of each marker
protein and second antibodies (dilution 1:2,000). B. Electron
micrograph of isolated mitochondrial samples from cells (20,000 ×).
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lated mitochondrial samples, where mitochondria had typ-
ical membrane architecture. All the results showed that
isolated mitochondrial samples were full of intact mito-
chondria, though little contaminated by other sub-cellular
compartments.
Detection of mitochondrial DEPs between metastatic and
nonmetastatic cells by 2D-DIGE
Mitochondrial protein expressions were compared be-
tween metastatic 5-8F and nonmetastatic 6-10B cellsusing 2D-DIGE with a mixed-sample internal standard.
After comparative analyses by DeCyder 5.0 software in all
9 protein-spot image maps, average of 1,047 ± 78 protein-
spots were detected, in total 36 spots containing DEPs (X-
fold5-8F/6-10B > 2, P < 0.05) were detected. Figure 2A
showed a representative two-color merged gel image.
Figure 2B showed 36 spots containing DEPs. Figure 2C
showed the three-dimensional simulation, a close-up of
the region of 2D-DIGE gel image, and the associated
graph view of an up-regulated protein (spot 2). Figure 2D
showed the three-dimensional simulation, a close-up of
the region of 2D-DIGE gel image, and the associated
graph view of a down-regulated protein (spot 15).
Identification of mitochondrial DEPs between metastatic
and nonmetastatic cells by PMF and MS/MS
All of 36 gel-spots that contained DEPs were excised
from the stained preparative gel. The proteins in each
excised gel spot were subjected to in situ digestion
with trypsin, and analyzed with MALDI-TOF PMF and
ESI-Q-TOF MS/MS. All PMF-based identification data
were collected in the supplementary mass spectral data
(Additional file 1: Figures 1-13). All MS/MS-based iden-
tification data were collected in the supplementary mass
spectral data (Additional file 1: Figures 14-19). A total of
16 DEPs were identified, including 4 down-regulated
proteins (IDH3B, COX5A, SERPINB5, and MRPL12)
and 12 up-regulated proteins (PRDX3, PRDX6, SOD2,
PDIA5, ETFA, VDAC1, VDAC2, ECH1, PHB, EIF5A,
PSMC4, and CALU) (Table 1). Those DEPs function in
mitochondria ATP synthesis, ion transport, hydrogen
peroxide metabolic process, DNA damage response,
apoptosis, cell redox homeostasis, respiratory electron
transport, fatty acid beta-oxidation, regulation of tran-
scription, protein biosynthesis, and mitochondrial mem-
brane potential.
Functional enrichment analyses of mitochondrial DEPs
and protein-protein interaction data
Functional enrichment categories that characterized
mitochondrial DEPs were identified. The functional en-
richment maps of biological process (Figure 3) and mo-
lecular function (Figure 4) were shown. The statistical
significantly enriched biological processes and molecular
functions (p < 0.05) were listed in Table 2. Biological
processes such as cellular response to reactive oxygen
species, hydrogen peroxide metabolic process, regulation
of mitochondrial membrane potential, cell redox home-
stasis, and oxidation reduction were enriched. Molecular
functions such as oxidoreductase activity, caspase inhibi-
tor activity, peroxiredoxin activity, porin activity, and
antioxidant activity were enriched. These results obvi-
ously showed that chiefly enriched proteins for the iden-
tified mitochondrial DEPs were oxidoreducition-related
Figure 2 2D-DIGE analysis of metastatic 5-8F versus
nonmetastatic 6-10B cells. A. A representative two-color merged
2D-DIGE gel image. Green is the Cy3-labeled metastatic 5-8F cell
sample. Red is the Cy5-labeled 6-10B cell sample. B. Labeled
differentially expressed proteins (DEPs) between metastatic (5-8F)
and nonmetastatic (6-10B) cell mitochondria (Ratio = 5-8F/6-10B;
Red: down-regulated; Green: up-regulated). C. Three-dimensional
simulation, a close-up of the region of 2D-DIGE gel image, and the
associated graph view of a representative up-regulated protein in
metastatic 5-8F cell mitochondria (spot 2). D. Three-dimensional
simulation, a close-up of the region of 2D-DIGE gel image, and the
associated graph view of a representative down-regulated protein in
metastatic 5-8F cell mitochondria (Spot 15).
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oxidoreducition-related processes.
After data extraction from HPRD and NCBI databases,
a protein-protein interaction sub-network of mitochon-
drial DEPs was generated. These results only extended
one layer connection, contained 193 nodes and 252
edges (Figure 5). In this complex sub-network, the col-
ored circles (nodes) represented proteins and the blue
full lines (edges) represented protein-protein interac-
tions. The nodes representing 16 DEPs were labeled in
yellow (up-regulated) or green (down-regulated). Seven
DEPs that interacted more proteins were VDAC1,
VDAC2, PRDX3, PRDX6, SOD2, PHB, and PSMC4.
These interaction data provided important clues to
insight into the molecular mechanisms of NPC
metastasis.
Validation of PRDX3 expression in mitochondria of
metastatic and nonmetastatic cells by Western blotting
Western blotting was conducted to confirm differential
expression of PRDX3 in mitochondria of metastatic 5-8F
cells compared with nonmetastic 6-10B cells. Equal
amount (60 μg) of mitochondrial proteins of metastatic
5-8F and nonmetastatic 6-10B cells were applied to 12%
SDS-PAGE and then transferred to PVDF membranes
using COX IV as internal standard. The results showed
that PRDX3 was significantly up-regulated (about 240%)
in mitochondria of metastatic 5-8F cells relative to non-
metastatic 6-10B cells (Figure 6). It was consistent with
the 2D-DIGE result.
Efficiency of PRDX3 siRNA transient transfection in
mitochondria of metastatic 5-8F cells
Efficiency of the PRDX3 siRNA (sc-40833) transient
transfection of metastatic 5-8F cells was tested with
Western Blotting, using a scrambled sequence siRNA
(sc-44230) as control. The result data showed PRDX3
expression in mitochondria of metastatic 5-8F cells with
PRDX3 siRNA transient transfection was down-regulated
(about 65%) compared with metastatic 5-8F cells without
PRDX3 siRNA transient transfection (Figure 7). It demon-
strates that expression of PRDX3 was inhibited in the
mitochondria of NPC metastatic 5-8F cells with PRDX3
siRNA treatment.
Count of metastatic 5-8F cells migrated in Transwell
Migration assay
In three independent experiments, the number of cells
migrated through Transwell insert membrane was
counted for four experimental groups: Group A (nonme-
tastatic 6-10B cells; 0 ± 0), Group B (metastatic 5-8F
cells; 647 ± 35), Group C (metastatic 5-8F cells with
PRDX3 siRNA transient transfection; 838 ± 31), and
Group D (metastatic 5-8F cells with a scramble sequence
Table 1 Differentially expressed proteins in mitochondria of metastatic 5-8F compared to non-metastatic 6-10B cells,



















Peroxiredoxin 3 2 gi|
119569781
PRDX3 Mitochondria 24,941 5.73 90 5 9 PMF 43 +2.2
Peroxiredoxin 6 10 gi|4758638 PRDX6 Mitochondria,
lysosome
25,133 8.36 71 5 8 PMF 21 +2.5
Superoxide dismutase 13 gi|
67782309
SOD2 Mitochondria 20,882 8.36 71 4 4 PMF 52 +3.3
[Mn], mitochondrial isoform B
precursor
62 2 \ MS/
MS
8
Isocitrate dehydrogenase 12 gi|5031777 IDH3B Mitochondria 40,022 6.47 75 6 10 PMF 15 -3.3
[NAD] subunit alpha,
mitochondrial precursor





5 gi|1710248 PDIA5 Endoplasmic
reticulum
46,512 4.95 166 9 4 PMF 37 +2.4




COX5A Mitochondria 16,923 6.30 72 4 3 PMF 38 -4.4
Electron transfer 6 gi|2781202 ETFA Mitochondria 33,418 6.95 73 4 2 PMF 27 +2.6
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VDAC2 Mitochondria 30,842 8.00 101 6 5 PMF 34 +2.2







ECH1 Mitochondria 36,136 8.16 105 7 10 PMF 44 +4.1





43,690 5.99 225 5 \ MS/
MS
15 -3.2
Eukaryotic initiation factor 5A 14 gi|4261795 EIF5A Endoplasmic
reticulum




subunit 7 isoform 1
3 gi|4506209 PSMC4 Mitochondria,
proteasome
49,002 5.71 92 6 2 PMF 19 +2.0
Ribosomal protein L7/L12,
mitochondria
8 gi|1313962 MRPL12 Mitochindria 21,593 9.04 86 4 \ MS/
MS
19 -3.9




38,141 4.47 124 8 9 PMF 31 +2.9
NMP, the number of matched peptides. NUP, the number of unmatched peptides. MOI, methods of identification.
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Group C was about 40% more than the number of
Group B and Group D (P < 0.05). The effect of PRDX3
siRNA transient transfection on migration capability of
metastatic 5-8F cells was showed (Figure 8). It demon-
strates that suppression of PRDX3 in metastatic 5-8F
cells increased its mobility potential.Discussion
Nasopharyngeal carcinoma (NPC) is a malignant tumor
with a high incidence of metastasis, has a great tendency
to invade adjacent regions and metastasize to regional
lymph node and distant organs. Though the molecular
mechanisms of NPC metastasis remain poorly under-
stood, the functions of mitochondria that involved in
Figure 3 Enriched biological processes of differentially expressed mitochondrial proteins between metastatic 5-8F and nonmetastatic
6-10B cells. A circle represents a biological process. An arrow represents the relationship between two biological processes. The color from white
to deep yellow represents different p-values.
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dria are closely related to oxidative stress process in a
cell. Different from the historical views, which assumed
oxidative stress contributes to tumor initiation and pro-
gression solely by inducing genomic instability, the
present views consider oxidative stress directly contri-
butes to tumor metastasis. According to the tumor-
stroma co-evolution model, cancer cells induce oxidative
stress in adjacent stromal cells and result in an excessproduction of ROS in mitochondria. Excess stromal
ROS induces cytoskeleton rearrangements, autophagy,
and mitophagy in the tumor microenvironment to help
cancer cells escape excess ROS in the primary tumor
site, also induces the stromal over-production of
recycled nutrients such as ketones and L-lactate that are
fuel for tumor growth and metastasis [10-16]. Moreover,
the enhanced cellular antioxidant capability and antioxi-
dant function of redox-signaling in cancer cells result in
Figure 4 Enriched molecular functions of differentially expressed mitochondrial proteins between metastatic 5-8F and nonmetastatic
6-10B cells. A circle represents a molecular function. An arrow represents the relationship between two molecular functions. The color from
white to deep yellow represents different p-values.
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cells themselves from oxidative damage, and favor their
metastasis [14].
In general the balance between ROS generation and
elimination is delicately maintained in cells. However,
for many cancer cells, an increase in ROS production or
decrease in ROS-scavenger capacity disturbs redox
homeostasis which leads to an overall increase of intra-
cellular ROS level. Over-expressed catalase to alleviatemitochondrial oxidative stress in a mouse animal model
of breast cancer could reduce metastatic tumor burden
by >12-fold [13]. Considered this catalase experimental
result and our PRDX3 study, it is very likely that a mo-
lecular network based on redox-signaling pathways in
cancer cells directly contributes to tumor metastasis, this
process relates closely to mitochondrial oxidative stress
and ROS produced by mitochondria might play an im-
portant role in tumorigenesis (its direct action on
Table 2 Enriched Go terms of differentially expressed proteins in mitochondria of metastatic 5-8F relative to non-
metastatic 6-10B cells
GO-ID Description P-Value Genes
Biological Process
34614 Cellular response to reactive oxygen species 7.09E-6 PRDX6↑, PRDX3↑, SOD2↑
42743 Hydrogen peroxide metabolic process 2.39E-6 PRDX6↑, PRDX3↑, SOD2↑
51881 Regulation of mitochondria membrane potential 5.62E-5 PRDX3↑, SOD2↑
45454 Cell redox homeostasis 3.92E-5 PRDX6↑, PDIA5↑, PRDX3↑
55114 Oxidation reduction 2.92E-5 PRDX6↑, IDH3B↓, PDIA5↑, PRDX3↑, ETFA↑, SOD2↑
Molecular Function
16491 Oxidoreductase activity 2.64E-6 PRDX6↑, IDH3B↓, PDIA5↑, PRDX3↑, COX5A↓, ETFA ↑, SOD2↑
43027 Caspase inhibitor activity 6.61E-5 PRDX6↑, PRDX3↑
51920 Peroxiredoxin activity 1.51E-5 PRDX6↑, PRDX3↑
15288 Porin activity 1.51E-5 VDAC2↑, VDAC1↑
16209 Antioxidant activity 1.35E-5 PRDX6↑, PRDX3↑, SOD2↑
↑ : up- regulated expression in metastatic 5-8F cells relative to non-metastatic 6-10B cells.
↓ : down-regulated expression in metastatic 5-8F cells relative to non-metastaic 6-10B cells.
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tastasis as well.
Each mitochondrial DEP was rationalized in the
tumor-stroma co-evolution model, and an experimental
data-based diagram was proposed (Figure 9). In our
comparative proteomic study of mitochondria between
NPC metastatic 5-8F and nonmetastatic 6-10B cells, the
first five enriched GO terms of DEPs were closely related
to oxidative stress (Table 2). For PRDX3, our compara-
tive proteomic data demonstrated the expression of
PRDX3 in mitochondria of metastatic 5-8F cells is
higher than in mitochondria of nonmetastatic 6-10B
cells, it shows that the anti-oxidative stress capability in
metastatic 5-8F cells is stronger than nonmetastatic 6-
10B cells. This result is consistent with previous conclu-
sion [14] that the enhanced anti-oxidant capabilities in
cancer cells defend themselves from excess stromal oxi-
dative damage and favors cell metastasis. Furthermore,
among several DEPs (data not showed) selected to carry
out siRNA transient transfections and then Transwell
Migration assay, only suppression of PRDX3 expression
resulted in the significantly increased number of cells
migrated through Transwell membrane (P < 0.05).
PRDX3, mitochondria thioredoxin-dependent peroxide
reductase, is the main way by which cancer cells reduce
their levels of H2O2 built up during active respiration
[17,18], suppression of this enzyme, a scavenger of per-
oxide, could increase oxidative stress in cancer cells to
up-regulate the redox-signaling, promote the glycolysis,
proliferation, and survival, and finally lead increased
cells mobility potential [14] (Figure 8). To our know-
ledge, this was the first experimental evidence that
PRDX3 was related to NPC metastasis.PRDX6 increased about 2.5-fold in mitochondria of
metastatic 5-8F cells than in mitochondria of nonmeta-
static 6-10B cells. This result was consistent with the
results of other research groups: PRDX6 expressions
were increased in node-positive breast carcinoma sam-
ples compared with node-negative breast carcinoma
samples [19]; enzymatic activities of PRDX6 in lung
cancer cells metastasis [20]; over-expression of PRDX6
led to a more invasive phenotype and metastatic poten-
tial in human breast cancer [21]. Over-expression of
PRDX6 is on the one hand to strengthen the peroxidase
activity of a cell to reduce peroxidants such as H2O2
and hydroperoxides for the relief of oxidative stress. Be-
sides of its peroxidase activity, PRDX6 has additional
phospholipase A2 (PLA2) activity, this activity promotes
accumulation of arochidonic acid, which, in turn,
induces the invasive pathway involving p38 kinase, phos-
phoinositide 3-kinase, Akt and urokinase-type plasmino-
gen activator. Over-expression of PRDX6 leads to a
more invasive phenotype and metastasis potential, at
least in part, through regulation of the levels of uPAR,
Ets-1, MMP-9, RhoC, and TIMP-2 expression [20,21].
Therefore, PRDX6 in NPC metastatic process demon-
strates a double-side effect. To our knowledge this was
the first report of the relationship between PRDX6 and
NPC metastasis.
SOD2 increased in many tumor types as they progress
from early stage non-invasive disease to late stage meta-
static disease, and its over-expression in many instances
enhance the metastasis phenotype because SOD2 is able
to catalize toxic oxidant O2
.- into another toxic oxidant
H2O2 and hydroperoxides, and O2
.- and H2O2 / hydro-
peroxides both directly contribute to oxidative stress.
Figure 5 A protein-protein interaction sub-network of differentially expressed mitochondrial proteins between metastatic 5-8F and
nonmetastatic 6-10B cells. It contains 193 nodes (red, green and yellow circles) and 252 edges (blue lines). A green circle means a
down-regulated protein in metastatic 5-8F cells relative to nonmetastatic 6-10B cells. A yellow circle means an up-regulated protein in metastatic
5-8F cells relative to nonmetastatic 6-10B cells.
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efficient H2O2 scavenging [22-26]. Our proteomic results
also showed that SOD2 increased about 3.3-fold in mito-
chondria of metastatic 5-8F than in nonmetastatic 6-10B
cells. To our knowledge this was the first report of the
relationship between SOD2 and NPC metastasis.
Over-expression of ECH1 can enhance the energy
generation, and promote adhension and migration cap-
ability of cancer cell for cancer metastasis. The presentexperimental data showed that ECH1 increased in 4.1-
fold in mitochondria of NPC metastatic 5-8F than non-
metastatic 6-10B cells. This result was consistent with
the other studies [27], a higher expression level of
ECH1 was confirmed in tissue from patients with gas-
tric carcinoma with lymph node metastases, and down-
regulation of ECH1 could inhibit tumor proliferation,
increase the ratio in S phase to G1 phase and decrease
the adhesion and migration capacity.
Figure 6 Up-regulated expressions of PRDX3 in metastatic 5-8F
cell mitochondria relative to nonmetastatic 6-10B cell
mitochondria without significant expression difference in the
level of whole cells. A. Western blotting image. B. The quantitative
comparison of the digitized Western blotting image. COXIV, a
marker protein of mitochondria, was used as a reference standard
protein when mitochondrial protein sample was analyzed with
Western blot. ACTIN that is mainly expressed in the cytoplasm was
used a reference standard protein when whole-cell protein sample
was analyzed with Western blot. Western blot experiments were
carried out triply (n = 3).
Figure 7 Effects of PRDX3 siRNA transient transfection on the
PRDX3 expression of metastatic 5-8F cells. Suppression of PRDX3
expression in the levels of mitochondria and whole cells of the
metastatic 5-8F cells treated with siRNA relative to without siRNA
and control siRNA treatments. The top shows the Western blotting
image. The bottom shows the quantitative comparison of the
digitized Western blotting image. COXIV, a marker protein of
mitochondria, was used as a reference standard protein when
mitochondrial protein sample was analyzed with Western blot.
ACTIN that is mainly expressed in the cytoplasm was used a
reference standard protein when whole-cell protein sample was
analyzed with Western blot. Western blot experiments were carried
out triply (n = 3).
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gene could effectively suppress the invasiveness and mo-
tility of malignant cancer cells. Nuclear localization of
SERPINB5 is required for its tumor metastasis suppres-
sor function and it was enriched at the promoter of
colony-stimulating factor (CSF-1) in chromatin immu-
noprecipitation and associated with diminished levels of
CSF-1 mRNA. It suggests that its mechanism of action
involves, in part, direct association of SERPINB5 with
target genes to inhibit metastatic phenotype [29]. The
present studies showed a down-regulation of SERPINB5
by 3.2-fold in mitochondria of NPC metastatic 5-8F than
nonmetastatic 6-10B cells. Thus, the down-regulated
SERPINB5 might enhance the metastatic capability of an
NPC cancer cell.
COX subunit composition is regulated by COX5A and
COX5B gene transcription in response to high and lowO2, respectively. This subunit switch maintains mito-
chondria redox homeostasis and relates to morpho-
logical and functional alteration of mitochondria [30].
PDIA5 also directly involves in the redox homeostasis.
The present studies demonstrate that the down-
regulation of COX5A and up-regulation of PDIA5 in
NPC metastatic 5-8F cells relative to nonmetastatic 6-
10B cells. The abnormal expression of COX5A and
Figure 8 Effects of PRDX3 siRNA transient transfection on the migration capability of metastatic 5-8F cells. Effect of PRDX3 siRNA
transient transfection on migration capability of metastatic 5-8F cells. The top shows four representative micrographs of metastatic 5-8F cells
migrated through Transwell insert membranes among four experimental groups (400 ×). The bottom shows the quantitative comparison of the
number of cells that migrated through Transwell insert membranes. Group A (a): nonmetastatic 6-10B cells. Group B (b): metastatic 5-8F cells.
Group C (c): metastatic 5-8F cells with PRDX3 siRNA transient transfection. Group D (d): metastatic 5-8F cells with a scramble sequence siRNA
transient transfection. Transwell migration assays were carried out triply (n = 3).
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http://www.biomedcentral.com/1755-8794/5/62PDIA5 in NPC metastatic 5-8F cells might disturb the
redox homeostasis to contribute to its metastatic
process.
Studies [31] demonstrated over-expression of EIF5A
enhances cell motility and promotes tumor metastasis in
hepatocellular carcinoma. It was able to induce
epithelial-mensenchymal transition (EMT), a key event
in tumor invasion and metastasis, characterized by
down-regulation of epithelial markers (E-cadherin and
beta-catenin) and up-regulation of mesenchymal mar-
kers (fibronectin, N-cadherin, alpha-SMA and vimentin).
It could also stimulate cytoskeleton rearrangement
through activation of RhoA/Rac1 to contribute to the
cancer cell metastasis. The present data showed EIF5A
increased 2.5-fold in mitochondria of NPC metastatic 5-8F than nonmetastatic 6-10B cells. It suggests that over-
expressed EIF5A contributes to NPC cancer cell
metastasis.
IDH3B [32] involves in the mitochondrial tricarboxylic
acid cycle that is initiated by acetyl-CoA. Acetyl-CoA is
derived from the travel of pyruvic acid from cytoplasm
into the interior of the mitochondrion. Pyruvic acid is
generated from the glycolysis of glucose. The current
study demonstrated the down-regulation of mitochon-
drial IDH3B in NPC metastatic 5-8F cells. Down-
regulated IDH3B will obstacle the tricarboxylic acid
cycle to reduce the generation of ATP, cause energy me-
tabolism obstacle and mitochondrial dysfunction, and
promote oxidative stress. Meanwhile, the tricarboxylic
acid cycle obstacle will built up the pyruvic acid. Studies
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Figure 9 Experimental data-based diagram that rationalizes differentially expressed mitochondrial proteins in a tumor-stroma co-
evolution model. ↑: up-regulated protein in metastatic 5-8F cells relative to nonmetastatic 6-10B cells. ↓: down-regulated protein in metastatic 5-
8F cells relative to nonmetastatic 6-10B cells. The green frame means the relationship between proteins and tumor metastasis is unclear. The blue
frame means the relationship between proteins and tumor metastasis is, at least partially, clear. The blue frame with solid line means protein
promotes metastasis and the blue frame with dotted line means protein inhibits metastasis. SOD2, superoxide dismutase [Mn] mitochondrial
isoform B; PRDX3, peroxiredoxin 3; PRDX6, peroxiredoxin 6; ECH1, mitochondrial delta(3,5)-delta(2,4)-dienoyl-CoA isomerase; SERPINB5, maspin;
COX5A, mitochondrial cytochrome c oxidase subunit 5A; PDIA5, protein disulfide; EIF5A, eukaryotic initiation factor 5A; IDH3B, mitochondrial
isocitrate dehydrogenase [NAD] subunit alpha; ETFA, electron transfer flavoprotein; PHB, prohibitin; MRPL12, mitochondrial ribosomal protein L7/
L12; PSMC4, 26S protease regulatory subunit 7 isoform 1; VDAC1 and VDAC2, voltage-dependent anion channel 1 and 2; and CALU, calumenin
isoform c precursor.
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genic activity and plays an important role in angiogen-
esis for tumor growth and metastasis.
PSMC4 is a 26S protease that is involved in the ATP-
dependent degradation of ubiquitinated proteins in the
ubiquitin-proteasome system (UPS) that is extensively
associated cancer pathogenesis [34]. The UPS plays a
central role in fine-tuning the functions of core proan-
giogenic proteins including VEGF, VEGFR-2, angiogenic
signaling proteins such as the PLCy1 and PI3 kinase/
AKT pathways, and other non-VEGF angiogenic pathways
to regulate the tumor angiogenesis [35]. The up-regulation
of PSMC4 would contribute to this angiogenesis process
for tumor metastasis.
Moreover, ETFA is a mitochondrial electron transfer
flavoprotein [36]. The ETFA up-regulation in NPC meta-
static cell could promote mitochondrial electron trans-
port and oxidative phosphorylation, and enhance
mitochondrial oxidative stress. Prohibitin (PHB) is apro-oncogene, inhibits DNA synthesis, and regulates
proliferation. However, PHB gene mutated in human
cancers [37], PHB protein responds to mitochondrial
stress and may play a role in regulating mitochondrial
respiration activity [38]. MRPL12 may act as a scaffold-
ing protein or stabilizer of respiratory chain supercom-
plexes, is involved in regulation of mitochondrial protein
translation and respiration, and plays a role in
mitochondrial-mediated death. The current studies
found down-regulation of MRPL12, which would regu-
late mitochondria-mediated cell death and respiration
[39,40]. VDAC1 and VDAC2 forms a channel through
the mitochondrial outer membrane with a weak anion
selectivity at the open state and a cation-selectivity at
the close state [41,42], and GALU is involved in the
binding of calcium ions [43]. The current studies
showed the up-regulated expression of VDAC1, VDAC2,
and GALU, they would disturb the mitochondrial ion
homeostasis in the mitochondrial dysfunction and
Liu et al. BMC Medical Genomics 2012, 5:62 Page 13 of 17
http://www.biomedcentral.com/1755-8794/5/62oxidative stress. The relationship of those mitochondrial
DEPs and the tumor metastasis needs to be validated
with experiments; however, these data are novel clues to
insight into the mechanisms of NPC metastasis.
Conclusions
In summary, the present study provides new insights for
exploring the significance of mitochondria and oxidative
stress in NPC metastatic processes. Ten mitochondrial
DEPs including PRDX3, PRDX6, SOD2, ECH1, SER-
PINB5, COX5A, PDIA5, EIF5A, IDH3B, and PSMC4
have been rationalized in the tumor-stroma co-evolution
model that mitochondrial oxidative stress directly con-
tributes to tumor metastasis (Figure 9). The expression
suppression of mitochondrial PRDX3 protein in the
anti-oxidative stress system enhanced the mobility po-
tential of NPC metastatic cancer cells, which consoli-
dates the roles of mitochondrial oxidative stress in NPC
metastasis. Further investigation is required to deter-
mine the biological consequences of all identified mito-
chondrial DEPs and their relevance to the pathogenic
mechanisms of NPC metastasis.
Methods
Materials
All primary and secondary antibodies, siRNA duplex
and a scrambled sequence control siRNA were from
Santa Cruz. LipofectamineTM RNAiMAX transfection
reagents and serum-free medium were from Invitrogen.
Immobiline DryStrip gels (pH 3-10 NL, 24 cm), CyDye
DIGE fluor Cy2, Cy3 and Cy5 were from GE Healthcare.
Matrigel basement membrane matrix was from BD Bios-
ciences. Transwell plates and inserts (Cat. No. 3422)
were from Corning. All other chemicals, unless stated
otherwise, were obtained from Sigma.
Cells culture
NPC 5-8F and 6-10B cells were obtained from the Mod-
ern Analytical Testing Center of Central South Univer-
sity of China. Cells were cultured in RPMI 1640 medium
supplemented with 10% fetal bovine serum (FBS) and
antibiotics in a humidified incubator with 5% CO2 in air
at 37°C. The cells were grown to 80% confluence, washed
twice with D-Hank’s solution, digested with 0.25% trypsin
and 0.02% ethylenediaminetetraacetate dehydrate
(EDTA), collected by centrifugation (400 × g, 10 min, 4°C).
A total of ~2 × 107 cells were needed for experiments.
Preparation and characterization of mitochondria, and
extraction of mitochondrial proteins
Mitochondria were isolated from 5-8F and 6-10B cells,
respectively, according to the Sucrose Gradient Separ-
ation Manual (www.mitosciences.com) with a minor
modification. Briefly, the collected cells described abovewere resuspended in five volumes of Mito buffers (0.25 M
sucrose, 1 mM EDTA, 10 mM Tris•HCl pH 7.4, 1 mM
phenylmethanesulfonyl fluoride (PMSF), 1 mg/ml leupep-
tin, 1 mg/ml pepstatin) and homogenized by pre-cooled
Potter-Elvehjem homogenizer (1,000 rpm; around 20 up
and down strokes). The homogenates were centrifuged
(1,000 × g, 10 min, 4°C) to collect the supernatants. The
supernatants were centrifuged (12,000 × g, 15 min, 4°C)
to collect the pellets. The pellets were resuspended in
0.5 ml Mito buffers. The discontinuous sucrose gradient
separation solutions were prepared in centrifuge tubes
with gradient from bottom to top that is 0.5 ml of 2.0 M
sucrose, 1 ml of 1.3 M sucrose, 1 ml of 1.0 M sucrose,
and 0.5 ml of 0.8 M sucrose. The resuspended samples
were carefully applied to the top of gradient solutions and
centrifuged (80,000 × g, 2 h, 4°C; Beckman swinging
bucket 55 Ti rotors). The brown belts between 1.0 M and
1.3 M sucrose layers were collected carefully with a 5-ml
syringe needle immediately after centrifugation. A volume
(600 μl) of methanol was added to the top of 150 μl
brown sucrose solution, and mixed; then 150 μl of
chloroform and 450 μl of water were added, mixed again,
and centrifuged (18,000 × g, 5 min, 4°C). All organic and
inorganic liquids in centrifuge tubes were poured off care-
fully, followed by air dry at 4°C of the white discs of pro-
teins. The white discs of proteins were solubilized (2 h;
intermittent mix) in 800 μl lysis buffer that contained
8 M urea, 2 M thiourea, 130 mM dithiothreitol (DTT) ,
4% 3-[(3-cholanidopropyl) dimethylammonio] -1-propa-
nesulfonate (CHAPS), 40 mM tris base, 1 mM EDTA,
1 mM PMSF, 1 mg/ml leupeptin, 1 mg/ml pepstatin, and
pH 8.5 adjusted by 50 mM NaOH, and centrifuged
(18,000 × g, 2 h, 4°C). The supernatants were collected.
The protein concentration of the supernatants was deter-
mined by a 2-D Quantification kit (GE Healthcare). The
isolated mitochondria were characterized according to
Murayama’s method [44]. Briefly, the extracted mitochon-
drial proteins were separated by 12% sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-PAGE) gels,
transferred to polyvinylidene fluoride (PVDF) membranes
(Semi-dry Nova blot, Pharmacia Biotech), probed with
various primary antibodies against marker proteins from
different cellular compartments (LDH, PCNA, COX IV,
catalase, GRP 78, and cathepsin D) and corresponding
secondary antibodies, and visualized by a SuperSingal
West Pico ECL kit (Thermo). Preparation of isolated
mitochondria for electron microscopic observation was
carried out according to the related manual and observa-
tion was made by a Hitachi H 7500 transmission electron
microscope.
2D-DIGE and imaging analyses
The 2D-DIGE experimental flow-chart was shown
(Figure 10). Briefly, Mitochondrial proteins were labeled
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Figure 10 The experimental flow-chart for two-dimensional difference in-gel electrophoresis (2D-DIGE).
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of Amersham CyDye DIGE Fluors (minimal dyes) for
Ettan DIGE Product Booklet. An amount (50 μg) of pro-
teins were labeled with 400 pmol of dyes (dark; on ice;
30 min) and then quenched (10 min) with 1 μl of 10 mM
lysine. Two sets of metastatic 5-8F cell proteins were la-
beled with Cy3 and the third set with Cy5. Two sets of
nonmetastatic 6-10B cell proteins were labeled with Cy5
and the third set with Cy3. Each set of above sample con-
tained 50 μg proteins. The internal standard (75 μg of
metastatic 5-8F cell proteins plus 75 μg of nonmetastatic
6-10B cell proteins) was labeled with Cy2. One set
(50 μg) of Cy3-labeled proteins was combined with one
set (50 μg) of Cy5-labeled proteins and combined again
with one third (50 μg) of Cy2-labeled internal standard
proteins. The combined sample was added in equal vol-
ume of 2 × sample buffer (8 M urea, 130 mM DTT, 4%
CHAPS, and 2% Pharmalyte 3-10), and then supplied
with rehydration buffer (8 M urea, 130 mM DTT, 4%
CHAPS, and 1% pharmalyte 3-10) to the total volume of
450 μl. The mixed sample (450 μl) was applied to an
immobiline DryStrip gel; and three analytic gels and one
preparative gel were simultaneously focused on an IPG-
phor Unit (GH Healthcare) with a total of 80,000 Vhr.
The focused proteins in the immobiline DryStrips were
equilibrated in a solution containing 65 mM DTT(15 min), and in another solution containing 135 mM
iodacetamide (15 min). The equilibrated proteins in the
immobiline DryStrip were separated by 12.5% SDS-
PAGE gels in an Ettan DALT II system (GE Healthcare).
After electrophoresis, each gel was scanned on a Ty-
phoon 9410 scanner (GE Healthcare) at appropriate
wavelengths that were specific for Cy2 (488/520 nm),
Cy3 (532/580 nm), and Cy5 (633/670 nm). In total 9
protein-spot image maps were generated. Each gel-spot
density was normalized by the total density in each
protein-spot image map. The DeCyder differential in-gel
analysis (DIA) module was used for pair-wise compari-
son of each 5-8F and 6-10B protein to the internal stand-
ard in each gel. The DeCyder biological variation analysis
(BVA) module was then used to simultaneously match all
9 protein-spot image maps. The normalized Cy3/normal-
ized Cy2 and normalized Cy5/normalized Cy2 DIA ratios
were used to calculate average abundance changes. The
average of three DIA ratios from metastatic cell 5-8F
mitochondria represents the relative expression level of a
protein in metastatic cell mitochondria, and the average
of three DIA ratios from nonmetastatic cell 6-10B mito-
chondria represents the relative expression level of a pro-
tein in nonmetastatic cell mitochondria. The paired
Student’s t-test p-values were used for the variance of
these ratios for each protein pair across all samples (all 9
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contained gel-spot. Each DEP-contained gel-spot was
excised for protein identification.
MS-identification of mitochondrial DEPs
The 2D gel spots that contained DEPs were excised from
the preparative gels. The proteins in the gel-spot were
destained, reducted, alkylated, and digested in gels with
trypsin [45]. For PMF analysis, the tryptic peptides were
eluted from ZipTips with 80% acetonitrile/0.1% trifluor-
oacetic acid, and were spotted onto a MALDI target
with an equal volume of cyano-4-hydroxycinnamic acid
(10 mg/ml; Sigma) saturated with 50%acetonitrile in
0.05% TFA. The mass spectrometric (MS) spectra were
acquired on a Voyager DE STR MALDI-TOF mass spec-
trometer (ABI, Foster City, CA). The instrument settings
were reflector mode with 160-ns delay extraction time,
positive polarity, and 20-kV accelerating voltage. The
spectrum mass-tocharge (m/z) were usually acquired
with laser shots at 200/spectrum and ranged from 1000
to 4000 m/z. External calibration was performed using a
Peptide Mass Standard kit (Perspective Biosystems, Fra-
mingham, MA). The acquired MS spectra were pro-
cessed with base-line correction, noise removal (5%),
and peak deisotoping using DataExplore (Version
4.0.0.0) software to generate the peaklist for peptide
mass fingerprint (PMF) analysis. The PMF data were in-
put into Mascot (www.matrixscience.com/) for protein
identity searching. The PMF data from the Voyager DE
STR mass spectrometer were searched against the
NCBInr database (release date January 7, 2012;
16,831,682 sequences, 5,781,564,572 residues; Homo
sapiens 241,934 sequences). The search was restricted to
“Human” as taxonomy. The other search parameters
included type of search (peptide mass fingerprint), en-
zyme (trypsin), fixed modifications (carbamidomethyl-
cysteine), variable modifications (methionine oxidation),
mass values (monoisotopic), protein mass (unrestricted),
peptide mass tolerance (100 ppm), peptide charge state
(1+), and 1 maximum missed cleavages. Proteins whose
scores were greater than 66 were considered as signifi-
cance (p < 0.05), and only human proteins with the best
score in each Mascot search were accepted as successful
identifications. The coverage of amino acid sequence,
the Mascot score, the mass and pI, and accession num-
ber are obtained for each protein.
Proteins in a 2D gel spot that was not identified or
was a mixture identified by MALDI-TOF PMF data were
subjected to electrospray ionization (ESI)-quadrople (Q)-
TOF MS/MS analysis. Briefly, the tryptic peptides from
2D gel spots were loaded onto a C18 pre-column for
concentrations and fast desalting, and then eluted to the
reversed-phase column for separation. MS/MS spectra
were performed in data-depended mode in which up tofour precursor ions above an intensity threshold of 7
counts/seconds (cps) were selected for MS/MS ana-
lysis from each survey scan. For MS/MS database
query, the peptide sequence tag (PKL) format file that
was generated from MS/MS data with MassLynx v 4.0
software were inputted into the Mascot search engine to
search protein against the NCBInr database (release date
January 7, 2012; 16,831,682 sequences, 5,781,564,572 resi-
dues; Homo sapiens 241,934 sequences). A mass tolerance
of 0.3 Da for both parent (MS) and fragmented (MS/MS)
ions, allowance for up to one trypsin miscleavage, variable
amino acid modifications consisting of methionine oxi-
dation and cysteine carbamidomethylation were used.
MS/MS ion score threshold was determined to pro-
duce a false-positive rate less than 5% for a significant
hit (P < 0.05). The false-positive rate was calculated with
2∗ reverse/(reverse + forward)/100. In the current study,
the MS/MS ion score threshold was 45 and a false-
positive rate was approximately 3.1%. Only protein
IDH3B was identified with only one peptide with a Mas-
cot score of 73, its MS/MS spectrum was further checked
manually and interpreted with de-novo sequencing.
Functional enrichment analyses of mitochondrial DEPs
and protein-protein interaction data
The gene names of mitochondrial DEPs were converted
to NCBI-Entrez format for consistency and saved as a
text file that was inputted into Cytoscape v 2.8.2 (www.
cytoscape.org), and BiNGO plugin 2.44 downloaded
from Cytoscape manage plugin was used to analyze the
enriched biological processes and molecular functions.
Human protein-protein interaction data that were down-
loaded from HPRD (release 9; www.hprd.org) and NCBI
databases (www.ncbi.nlm.nih.gov) were used to generate
a protein-protein interaction sub-network of mitochon-
drial DEPs; the result only extended one layer connec-
tion and could be visualized by Cytoscape.
siRNA transient transfection
The siRNA transient transfections of metastatic 5-8F
cells were conducted according to siRNA Transfection
Protocols (Santa Cruz) and Transfection Technology
Protocols (Invitrogen) with a minor modification. Briefly,
the cells were incubated in a six wells plate (Costar) at
37°C in a CO2 incubator till 70-80% confluence. The so-
lution A (2.4 μl RNAiMAX in 100 μl serum-free
medium) and solution B (10 μl siRNAs duplex in 100 μl
serum-free medium) were mixed gently (the final con-
centration in each well was 100 nM), and incubated
(room temperature; 45 min). Cells were washed twice
with serum-free medium, and then added into 200 μl of
above A + B mixture and 800 μl of serum-free medium
in each well. After cells were incubated (7 h), the
medium in each well were removed and replaced with
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ued to be incubated (48 h). Cells were washed twice with
D-Hank’s solution, digested with 0.25% trypsin and
0.02% EDTA, collected by centrifugation (400 × g;
10 min; 4°C). A scrambled sequence control siRNA ex-
periment was conducted at the same time. The efficiency
of siRNA transfection was tested by Western blotting.
Transwell Migration assays
Cells Transwell Migration assay was carried out accord-
ing to Matrigel Basement Membrane Matrix Product
Specification Sheet (BD Biosciences) and Transwell In-
sert Product Description (Corning) with a minor modi-
fication. Briefly, the Matrigel basement membrane
matrix was thawed (4°C; overnight), the Transwell
plates was put and inserted (both were added with
serum-free medium) in a CO2 incubator (37°C; 2 h).
The medium in Transwell plates was removed and
Transwell plates were inserted and kept on ice. Pre-
cooled pipettes were used to add 20 μl Matrigel matrix
(1:1 diluted with pre-cooled serum-free medium) into
each compartment of Transwell inserts and swirled im-
mediately to disperse materials evenly, placed Transwell
inserts (37°C; 30 min) to form thin Matrigel. A volume
(600 μl) of medium (RPMI 1640 with 10% FBS and
5 μg/ml fibronectin) was added to each Transwell plates
well, followed by adding the above thin Matrigel inserts,
then 200 μl medium and the cells (resuspended cells in
medium at a density of 5 × 104 cells/ml) were added
into each compartment of thin Matrigel inserts, and
incubated in a CO2 incubator (37°C; 24 h). All of these
experiments should be carefully handled using sterile
techniques. Those non-migrated cells on each compart-
ment of thin Matrigel inserts were scraped off with cot-
ton swabs, the migrated cells were fixed and stained by
0.1% crystal violet solution. The cells without siRNA
transient transfection and with a scrambled sequence
transfection were used as control groups. In three inde-
pendent experiments, the number of cells that migrated
through Transwell insert membrane was counted in 9
visual fields per well at 400 × under an Olympus micro-
scope, means of these counts were calculated for statis-
tical analysis using SPSS software, and variables were
compared using Student’s t-test with a significance level
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